|
NBEAL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.44613226843649E-13 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.30582219984399E-12 |
| Normal-vs-Stage2 |
7.19468928878086E-12 |
| Normal-vs-Stage3 |
1.6734391650175E-12 |
| Normal-vs-Stage4 |
1.97619698383278E-14 |
| Stage1-vs-Stage2 |
5.299200E-01 |
| Stage1-vs-Stage3 |
7.520200E-02 |
| Stage1-vs-Stage4 |
2.461800E-02 |
| Stage2-vs-Stage3 |
5.509200E-01 |
| Stage2-vs-Stage4 |
2.846800E-01 |
| Stage3-vs-Stage4 |
5.665400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.4491519923231E-13 |
| Normal-vs-AfricanAmerican |
3.50620000000301E-06 |
| Normal-vs-Asian |
4.69113636825114E-12 |
| Caucasian-vs-AfricanAmerican |
1.946610E-01 |
| Caucasian-vs-Asian |
8.066200E-01 |
| AfricanAmerican-vs-Asian |
1.750620E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.03090885722668E-14 |
| Normal-vs-Female |
9.59232693276135E-13 |
| Male-vs-Female |
7.074100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.39026634227957E-12 |
| Normal-vs-Age(41-60Yrs) |
1.12909681604378E-13 |
| Normal-vs-Age(61-80Yrs) |
1.81643589058922E-12 |
| Normal-vs-Age(81-100Yrs) |
1.954950E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.844300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.453370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.917200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.685200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.532200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.608200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.142190E-02 |
| Classical-VS-Follicular |
9.710800E-01 |
| Classical-VS-Other |
2.056200E-03 |
| Classical-VS-Normal |
3.28803650972986E-12 |
| Tall-VS-Follicular |
3.429600E-02 |
| Tall-VS-Other |
2.713000E-01 |
| Tall-VS-Normal |
4.54081217071689E-14 |
| Follicular-VS-Other |
2.335300E-03 |
| Follicular-VS-Normal |
2.55739873722405E-11 |
| Other-VS-Normal |
4.60242954858359E-12 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.90070181815827E-13 |
| Normal-vs-N1 |
2.03148609045911E-12 |
| N0-vs-N1 |
4.871200E-01 |
|
|
